Capital Financial (CPFH) 10-Q 15 May 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014	12-May-14
Document And Entity Information	'	'
Entity Registrant Name	'Capital Financial Holdings, Inc	'
Entity Central Index Key	'0000944696	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	1,670,288
Document Fiscal Period Focus	'Q1	'
Document Fiscal Year Focus	'2014	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
CURRENT ASSETS	'	'
Cash and cash equivalents	$1,218,661	$1,665,123
Accounts receivable (net of an allowance of $24,000 for 2014 and 2013)	2,020,402	1,733,765
Prepaids	69,166	77,915
Total current assets	3,308,229	3,476,803
PROPERTY AND EQUIPMENT	'	'
Property and equipment	391,524	387,974
Less accumulated depreciation	-308,156	-301,207
Net property and equipment	83,368	86,767
OTHER ASSETS	'	'
Goodwill	2,132,026	2,132,026
Severance escrow	257,475	257,412
Deferred tax asset - non - current	497,721	501,403
Other assets (net of accumulated amortization of $214,444 for 2014 and 2013)	180,841	180,663
Total other assets	3,068,063	3,071,504
TOTAL ASSETS	6,459,660	6,635,074
CURRENT LIABILITIES	'	'
Accounts payable	110,854	340,244
Commissions payable	2,032,875	1,861,049
Settlements payable	22,000	22,000
Line of credit	127,827	200,723
Other current liabilities	55,269	48,096
Total current liabilities	2,348,825	2,472,112
LONG-TERM LIABILITIES	'	'
TOTAL LIABILITIES	2,348,825	2,472,112
STOCKHOLDERS' EQUITY	'	'
Series A preferred stock – 5,000,000 shares authorized, $.0001 par value; 3,050,000 and 3,050,000 shares issued and 0 outstanding, respectively	305	305
Additional paid in capital – series A preferred stock	1,524,695	1,524,695
Common stock – 1,000,000,000 shares authorized, $.0001 par value; 1,241 and 1,446 shares issued and outstanding, respectively	1,241	1,241
Additional paid in capital - common stock	10,221,515	10,221,515
Accumulated deficit	-6,336,921	-6,284,794
Less Treasury stock, 3,050,000 preferred shares at $0.4262	-1,300,000	-1,300,000
TOTAL STOCKHOLDERS' EQUITY	4,110,835	4,162,962
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$6,459,660	$6,635,074

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013
CURRENT ASSETS	'	'
Allowance for doubtful accounts	$24,000	$24,000
OTHER ASSETS	'	'
Accumulated amortization	$214,444	$214,444
STOCKHOLDERS' EQUITY	'	'
Series A Preferred stock, par value	$5,000,000	$5,000,000
Series A Preferred stock shares authorized	0.0001	0.0001
Series A Preferred stock shares issued	3,050,000	3,050,000
Series A Preferred stock shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock shares authorized	1,000,000,000	1,000,000,000
Common stock shares issued	1,241	1,241
Common stock shares outstanding	1,446	1,446
Treasury stock	3,050,000	3,050,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
OPERATING REVENUES	'	'
Fee income	$366,267	$229,585
Commissions	4,968,635	5,109,867
Interest and other income	133,928	122,688
Total revenue	5,468,830	5,462,140
OPERATING EXPENSES	'	'
Compensation and benefits	301,365	300,349
Commission expense	4,866,481	4,758,550
General and administrative expenses	331,050	367,042
Depreciation	6,949	6,604
Total operating expenses	5,505,847	5,432,545
OPERATING INCOME (LOSS)	-37,017	29,595
OTHER (EXPENSES)	'	'
Interest expense	-6,274	-3,907
INCOME (LOSS) BEFORE INCOME TAX EXPENSE	-43,291	25,688
INCOME TAX EXPENSE	-8,836	-19,966
NET INCOME (LOSS)	($52,127)	$5,722
NET INCOME PER COMMON SHARE:	'	'
Basic	($42)	$4
Diluted	($42)	$4
Basic	1,241	1,446
Diluted	1,241	1,446

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'
Net Income (loss)	($52,127)	$5,722
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'
Depreciation	6,949	6,604
Provision for income taxes	24,925	7,126
Accounts receivable	-286,637	-145,866
Prepaids & Other	8,571	43,803
Severance escrow	-63	-63
Accounts Payable	-229,390	-57,293
Commissions Payable	171,826	271,345
Other liabilities	7,173	-60,779
Net cash (used in) provided by operating activities	-370,016	70,599
CASH FLOWS FROM INVESTING ACTIVITIES	'	'
Purchase of property and equipment	-3,550	-12,668
Net cash (used in) provided by investing activities	-3,550	-12,668
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Payments on short-term borrowings	-72,896	-125,668
Increase in settlements payable	'	22,000
Repayment of promissory note	'	-67,173
Net cash used by financing activities	-72,896	-170,841
NET DECREASE IN CASH AND CASH EQUIVALENTS	-446,462	-112,910
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	1,665,123	1,221,606
CASH AND CASH EQUIVALENTS AT END OF PERIOD	1,218,661	1,108,696
SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:	'	'
Cash paid for interest	$6,274	$5,512

1_BASIS_OF_PRESENTATION

1. BASIS OF PRESENTATION	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
NOTE 1 - BASIS OF PRESENTATION	'
	NOTE 1 - BASIS OF PRESENTATION
	The accompanying condensed consolidated financial statements of Capital Financial Holdings, Inc., a North Dakota corporation, and its subsidiary (collectively, the "Company"), included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the footnotes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2013, of Capital Financial Holdings, Inc., as filed with the SEC.  The condensed consolidated balance sheet at December 31, 2013, contained herein, was derived from audited financial statements, but does not include all disclosures included in the Form 10-K and applicable under accounting principles generally accepted in the United States of America.  Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America, but not required for interim reporting purposes, have been condensed or omitted.
	In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments (which are of a normal, recurring nature) necessary for a fair presentation of the financial statements.  The results of operations for the three months ended March 31, 2014, are not necessarily indicative of operating results for the entire year.

2_RECENTLY_ADOPTED_ACCOUNTING_

2. RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
NOTE 2 - RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS	'
	NOTE 2 – RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS
	A summary of our significant accounting policies is included in Note 1 of our 2013 Form 10-K filed on March 18, 2014

3_RECLASSIFICATION

3. RECLASSIFICATION	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
NOTE 3 - RECLASSIFICATION	'
	NOTE 3 - RECLASSIFICATION
	Certain amounts in the 2013 condensed consolidated financial statements have been reclassified to conform to the 2014 presentation.  These reclassifications had no effect on the Company’s net income (loss).

4_GOODWILL

4. GOODWILL	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
NOTE 5 - GOODWILL	'
	NOTE 4 - GOODWILL
	The Company’s goodwill represents the excess of purchase prices over the fair value of the identifiable net assets of previously acquired broker/dealer businesses.  The goodwill is not amortized; instead it is tested for impairment annually or more frequently if the fair value of a reporting unit is below its carrying value. Absent any impairment indicators, the Company performs its annual goodwill impairment testing as of June 30 of each year.
	The Company’s policy is to test goodwill for impairment using a fair value approach at the reporting unit level.  The Company performs its goodwill impairment test in two steps.  Step one compares the fair value of the reporting unit to its carrying value, including goodwill.  If the fair value of the unit determined in step one is lower than its carrying value, the Company proceeds to step two, which then compares the carrying value of goodwill to its implied fair value.  Any excess of carrying value of goodwill over its implied fair value at a reporting unit is recorded as impairment.
	The valuation methodology the Company utilizes in testing the Company’s goodwill for impairment is based on the income approach.  The income approach is based on a discounted cash flow methodology in which expected future net cash flows are discounted to present value, using a discounted rate that compensates for the risk in attaining the projected cash flows.  This approach is dependent upon a number of significant management estimates about future performance including but not limited to, market performance, income taxes, capital spending and working capital changes.
	The Company tests goodwill for impairment annually during the second quarter of each fiscal year.  If an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value, goodwill will be evaluated for impairment between annual tests. There were no events that occurred nor a change in circumstances that would more likely than not reduce the fair value of a reporting unit below its carrying value during the first quarter in 2014. Therefore, the second step of testing for impairment was not required.

5_PROMISSORY_NOTE

5. PROMISSORY NOTE	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
NOTE 6 - PROMISSORY NOTE	'
	NOTE 5 – PROMISSORY NOTE
	On October 21, 2011, the Company issued a promissory note to PawnMart, Inc. in exchange for the repurchase of the 3,050,000 shares of preferred stock.  The note carries an interest rate of 7%, with quarterly payments of $66,801. On March 30, 2012 the Company revised the agreement with PawnMart, Inc. to release the building as security on the original note. The Company made a payment of $925,922. In April of 2012, the Company made a $100,000 payment. The Company was to make quarterly payments of $34,000 with the last payment being $34,965 until maturity April 1, 2014. On March 1, 2013, the Company made a payment of $118,000. On March 28, 2013 the Company paid the promissory note in full plus accrued interest for a total payment of $46,353. Interest expense on this note was $5,512 in 2013. There is no longer a liability related to this note.

6_LINE_OF_CREDIT

6. LINE OF CREDIT	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
NOTE 7. LINE OF CREDIT	'
	NOTE 6 – LINE OF CREDIT
	On August 9, 2013, the Company signed loan documents for a line of credit with a local bank, American Bank Center, in the amount of $300,000 in order to help fund the cash redemption of less than whole shares which resulted from the 1:10,000 reverse stock split, which occurred on August 14, 2013. The line of credit has a variable interest rate of 1.509 percent above Wall Street Journal U.S. Prime Rate which was 3.25% as of March 31, 2014. The Company makes monthly interest payments. The loan matures August 8, 2014.  The Company has set up monthly payments with an automatic payment of $25,000. As of March 31, 2014, the Company had outstanding $127,827 against its line of credit. As of March 31, 2014 interest expense on this line of credit was $3,661. There are no financial covenants associated with the line of credit.

7_STOCK_WARRANTS_STOCK_SPLITS_

7 - STOCK WARRANTS, STOCK SPLITS, AND STOCK OPTIONS	3 Months Ended
	Mar. 31, 2014
Stock Warrants Stock Splits And Stock Options	'
NOTE 8 - STOCK WARRANTS, STOCK SPLITS, AND STOCK OPTIONS	'
	NOTE 7 - STOCK WARRANTS, STOCK SPLITS, AND STOCK OPTIONS
	The Company measures and records compensation expense for all share-based payment awards made to employees and directors, including employee stock options, based on estimated fair values.  There were no compensation costs or deferred tax benefits recognized for stock-based compensation awards for the three months ended March 31, 2014 and 2013. Changes are due to the stock buyback and reverse stock split
	Option activity for the twelve months ended December 31, 2013 and the three months ended March 31, 2014 was as follows:
		Number of		Weighted Average Exercise Price per Share		Weighted Average Grant Date Fair Value		Aggregate
		Options						Intrinsic Value
	Outstanding on January 1, 2013		539	$	5,400	$	2,800	$	-
	Granted		-		-		-
	Exercised		-		-		-
	Canceled		-		-		-
	Outstanding on December 31, 2013		539	$	5,400	$	2,800	$	-
	Granted		-		-		-
	Exercised		-		-		-
	Canceled		20		-		-
	Outstanding on March 31, 2014		519	$	5,400	$	2,800	$	-
	Exercisable options totaled 538.8113 at December 31, 2013 and totaled 518.8113at March 31, 2014.

8_EARNINGS_PER_SHARE

8. EARNINGS PER SHARE	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
NOTE 8 - EARNINGS PER SHARE	'
	NOTE 8 - EARNINGS PER SHARE
	Basic earnings per share are computed by dividing earnings available to common shareholders by the weighted average number of common shares outstanding during the period.  Diluted earnings per share reflect per share amounts that would have resulted if dilutive potential common shares had been converted to common shares. Changes are due to the stock buyback and reverse stock split. The following reconciles amounts reported in the financial statements:
		Three Months Ended March 31, 2014								Three Months Ended March 31, 2013
		Numerator			Denominator		Per Share Amount			Numerator		Denominator		Per Share Amount
	Net (Loss) Income	$	(52,127	)							5,722
	Less:  Preferred Stock Dividends
	Income Available to Common Shareholders – Basic Earnings per Share	$	(52,127	)		1,241		(42	)		5,722		1,446	$	4
	Effect of Dilutive Securities:
	Preferred Stock Dividends
	Stock Options and Warrants
	Income Available to Common Shareholders – Diluted Earnings per Share	$	(52,127	)		1,241		(42	)		5,722		1,446	$	4
	Options and warrants to purchase 728.6113 common shares at exercise prices between $3,500 and $14,300 were outstanding at March 31, 2014, but were not included in the computation of diluted earnings per share for the quarter ending March 31, 2014 and March 31, 2013, because their effect was anti-dilutive.

9_FAIR_VALUE_DISCLOSURES

9. FAIR VALUE DISCLOSURES	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
NOTE 9 - FAIR VALUE DISCLOSURES	'
	NOTE 9 – FAIR VALUE DISCLOSURES
	The Company has adopted a framework for measuring fair value, and establishes a fair value hierarchy which prioritizes the inputs to valuation techniques.  Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market.  Valuation techniques that are consistent with the market, income or cost approach are used to measure fair value.
	The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value in three broad levels:
	● Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities the Company has the ability to access.
	● Level 2 inputs are inputs (other than quoted prices included within level 1) that are observable for the asset or liability, either directly or indirectly.
	● Level 3 are unobservable inputs for the asset or liability and rely on management’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.  (The unobservable inputs should be developed based on the best information available in the circumstances and may include the Company’s own data.)
	The application of valuation techniques applied to similar assets and liabilities has been consistently applied.  The following is a description of the valuation methodologies used for instruments measured at fair value: On February 12, 2009, CFS entered into a settlement agreement with a client, which resulted in CFS purchasing the client’s investment in the Omega 2007 Drilling Program 1, LP.  This limited partnership carries a “presentment” feature which allows CFS to sell the investment to the General Managing Partner of the limited partnership; and this feature has become available.  CFS had determined based off of the information provided by the Limited Partnership that the fair market value of the $76,876 investment was estimated at $45,000 based on discounted cash flows at the time of purchase by CFS which was included in other assets at December 31, 2013. Since then, CFS determined, based off of information provided by the Limited Partnership that, as of March 19, 2013, the fair market value of this $76,876 investment was $12,214, based on discounted cash flows. In May of 2013, CFS opted to exercise the “presentment” feature and was paid the current value of the investment in the amount of $11,923. No balance remains as of December 31, 2013.
	The Company has accumulated cash for the possible future payments of severance and benefits for senior management, should they leave. This is an accrual the company has elected to set aside for possible future obligations. These funds are reflected as Severance Escrow on the balance sheet, and consist of cash accounts.
		Carrying Value at March 31, 2014												Quarter ended
														31-Mar-13
		Total			Level 1			Level 2			Level 3			Total Losses
	Other Investment		$	-		$	-		$	-		$	-		$	-
	Severance Escrow			257,475			257,475			-			-			-
		Carrying Value at March 31, 2013												Quarter ended
														31-Mar-14
		Total			Level 1			Level 2			Level 3			Total Losses
	Other Investment		$	12,214		$	-		$	-		$	12,214		$	-
	Severance Escrow			254,259			254,259			-			-			-

10_LEGAL_PROCEEDINGS

10. LEGAL PROCEEDINGS	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
NOTE 10. LEGAL PROCEEDINGS	'
	NOTE 10 – LEGAL PROCEEDINGS
	The Company operates in a legal and regulatory environment that exposes it to potentially significant litigation risks. Issuers of certain alternative products sold by the Company are in Bankruptcy or may have other financial difficulties. As a result of such alleged failings of alternative products and the uncertainty of client recovery from the various product issuers, the Company is subject to several legal and/or arbitration proceedings. These proceedings include customer suits and arbitrations related to the failure of Medical Capital, other alternative investments alleged to be unsuitable, the bankruptcy proceedings of the various DBSI entities and the bankruptcy of other various entities. The Company vigorously contests the allegations of the various proceedings and believes that there are multiple meritorious legal and fact based defenses in these matters. Such cases are subject to many uncertainties, and their outcome is often difficult to predict, including the impact on operations or on the financial statements, particularly in the earlier stages of a case. The Company makes provisions for cases brought against it when, in the opinion of management after seeking legal advice, it is probable that a liability exists, and the amount can be reasonably estimated. The current proceedings are subject to uncertainties and, as such, the Company is unable to estimate the possible loss or range of loss that may result from the outcome of these cases; however, results in these cases that are against the interests of the Company could have a severe negative impact on the financial position of the Company. At March 31, 2014, the Company is a defendant in seven on-going suits or arbitrations as discussed above. The Company expects to vigorously defend and ultimately prevail in these cases. In April 2014, the Company settled one of the aforementioned lawsuits in the amount of $6,000. During 2012, the Company settled lawsuits that required a $22,000 payment in 2013 and an additional $22,000 payment during 2014. This payment was made during April of 2014. Subsequent to the quarter ended March 31, 2014, the Company received an additional complaint. Should the complaint become an arbitration, it would be covered under the Company’s liability insurance policy and any amounts of shared coverage by the Company to the insurance company is not material to the financial statements. No further payments will be required on the aforementioned settled proceedings.

7_STOCK_WARRANTS_STOCK_SPLITS_1

7 - STOCK WARRANTS, STOCK SPLITS, AND STOCK OPTIONS (Tables)	3 Months Ended
	Mar. 31, 2014
Stock Warrants Stock Splits And Stock Options	'
Option activity	'
	Option activity for the twelve months ended December 31, 2013 and the three months ended March 31, 2014 was as follows:
		Number of		Weighted Average Exercise Price per Share		Weighted Average Grant Date Fair Value		Aggregate
		Options						Intrinsic Value
	Outstanding on January 1, 2013		539	$	5,400	$	2,800	$	-
	Granted		-		-		-
	Exercised		-		-		-
	Canceled		-		-		-
	Outstanding on December 31, 2013		539	$	5,400	$	2,800	$	-
	Granted		-		-		-
	Exercised		-		-		-
	Canceled		20		-		-
	Outstanding on March 31, 2014		519	$	5,400	$	2,800	$	-

8_EARNINGS_PER_SHARE_Tables

8. EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
Basic Earning per share	'
	Changes are due to the stock buyback and reverse stock split. The following reconciles amounts reported in the financial statements:
		Three Months Ended March 31, 2014								Three Months Ended March 31, 2013
		Numerator			Denominator		Per Share Amount			Numerator		Denominator		Per Share Amount
	Net (Loss) Income	$	(52,127	)							5,722
	Less:  Preferred Stock Dividends
	Income Available to Common Shareholders – Basic Earnings per Share	$	(52,127	)		1,241		(42	)		5,722		1,446	$	4
	Effect of Dilutive Securities:
	Preferred Stock Dividends
	Stock Options and Warrants
	Income Available to Common Shareholders – Diluted Earnings per Share	$	(52,127	)		1,241		(42	)		5,722		1,446	$	4

9_FAIR_VALUE_DISCLOSURES_Table

9. FAIR VALUE DISCLOSURES (Tables)	3 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
Fair Value disclosure	'
	The Company has accumulated cash for the possible future payments of severance and benefits for senior management, should they leave. This is an accrual the company has elected to set aside for possible future obligations. These funds are reflected as Severance Escrow on the balance sheet, and consist of cash accounts.
		Carrying Value at March 31, 2014												Quarter ended
														31-Mar-13
		Total			Level 1			Level 2			Level 3			Total Losses
	Other Investment		$	-		$	-		$	-		$	-		$	-
	Severance Escrow			257,475			257,475			-			-			-
		Carrying Value at March 31, 2013												Quarter ended
														31-Mar-14
		Total			Level 1			Level 2			Level 3			Total Losses
	Other Investment		$	12,214		$	-		$	-		$	12,214		$	-
	Severance Escrow			254,259			254,259			-			-			-

6_LINE_OF_CREDIT_Details_Narra

6. LINE OF CREDIT (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Variable interest rate	1.51%
Prime Rate	3.25%
Interest expense	$3,661
outstanding line of credit	$127,827

7_STOCK_WARRANTS_STOCK_SPLITS_2

7. STOCK WARRANTS, STOCK SPLITS, AND STOCK OPTIONS (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Stock Warrants Stock Splits And Stock Options Details	'	'
Number of options, Outstanding Beginning	539	539
Number of options, Granted	'	'
Number of options, Exercised	'	'
Number of options, Canceled	20	'
Number of options, Outstanding Ending	519	539
Weighted Average Exercise Price per Share, Beginning	$5,400	$5,400
Weighted Average Exercise Price per Share, Granted	'	'
Weighted Average Exercise Price per Share, Exercised	'	'
Weighted Average Exercise Price per Share, Canceled	'	'
Weighted Average Exercise Price per Share, Ending	$5,400	$5,400
Weighted Average Grant Date Fair Value, Beginning	$2,800	$2,800
Weighted Average Grant Date Fair Value, Granted	'	'
Weighted Average Grant Date Fair Value, Exercised	'	'
Weighted Average Grant Date Fair Value, Canceled	'	'
Weighted Average Grant Date Fair Value, Ending	$2,800	$2,800
Aggregate Intrinsic Value, Beginning	'	'
Aggregate Intrinsic Value, Granted	'	'
Aggregate Intrinsic Value, Ending	'	'

7_STOCK_WARRANTS_STOCK_SPLITS_3

7. STOCK WARRANTS, STOCK SPLITS, AND STOCK OPTIONS (Details Narrative)	Mar. 31, 2014	Dec. 31, 2013
Stock Warrants Stock Splits And Stock Options Details Narrative	'	'
Exercisable options	518.8113	538.8113

8_EARNINGS_PER_SHARE_Details

8. EARNINGS PER SHARE (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Net (Loss) Income	($52,127)	$5,722
Income Available to Common Shareholders - Basic Earnings per Share	'	'
Numerator [Member]	'	'
Net (Loss) Income	-52,127	5,722
Less: Preferred Stock Dividends	'	'
Income Available to Common Shareholders - Basic Earnings per Share	-52,127	5,722
Effect of Dilutive Securities:	'	'
Preferred Stock Dividends	'	'
Stock Options and Warrants	'	'
Income Available to Common Shareholders - Diluted Earnings per Share	-52,127	5,722
Basic, per share amount	($42)	$4
Diluted, per share amount	($42)	$4
Denominator [Member]	'	'
Net (Loss) Income	'	'
Less: Preferred Stock Dividends	'	'
Income Available to Common Shareholders - Basic Earnings per Share	1,241	1,446
Effect of Dilutive Securities:	'	'
Preferred Stock Dividends	'	'
Stock Options and Warrants	'	'
Income Available to Common Shareholders - Diluted Earnings per Share	$1,241	$1,446
Basic, per share amount	'	'
Diluted, per share amount	'	'

8_EARNINGS_PER_SHARE_Details_N

8. EARNINGS PER SHARE (Details Narrative) (USD $)	3 Months Ended
	Mar. 31, 2014
Earnings Per Share Details Narrative	'
Incremental Common Shares Attributable to Call Options and Warrants	728.6113
Common shares minimum exercise prices	$3,500
Common shares maximum exercise prices	$14,300

10_FAIR_VALUE_DISCLOSURES_Deta

10. FAIR VALUE DISCLOSURES (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Components of accumulated cash for the possible future payments	'	'	'
Other Investment	'	'	$12,214
Severance Escrow	257,475	'	254,259
Total losses	'	'	'
Level 1 [Member]	'	'	'
Components of accumulated cash for the possible future payments	'	'	'
Other Investment	'	'	'
Severance Escrow	257,475	'	254,259
Level 2 [Member]	'	'	'
Components of accumulated cash for the possible future payments	'	'	'
Other Investment	'	'	'
Severance Escrow	'	'	'
Level 3 [Member]	'	'	'
Components of accumulated cash for the possible future payments	'	'	'
Other Investment	'	'	12,214
Severance Escrow	'	'	'